Schulich Heart Program, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada.
Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Catheter Cardiovasc Interv. 2024 Jan;103(1):202-208. doi: 10.1002/ccd.30910. Epub 2023 Nov 27.
Conduction disturbances and the need for permanent pacemaker (PPM) implantation remains a common complication for transcatheter aortic valve replacement (TAVR), particularly when self-expanding (SE) valves are used.
We compared in-hospital and 30-day rates of new PPM implantation between patients undergoing TAVR with SE valves using the conventional three-cusp coplanar implantation technique and the cusp-overlap technique.
We retrospectively compared patients without a pre-existing PPM who underwent a TAVR procedure with SE Evolut R or PRO valves using the cusp-overlap technique from July 2018 to September 2020 (n = 519) to patients who underwent TAVR using standard three-cusp technique from April 2016 to March 2017 (n = 128) in two high volume Canadian centers.
There was no significant difference in baseline RBBB between the groups (10.4% vs. 13.2; p = 0.35). The rate of in-hospital new complete heart block (9.4% vs. 23.4%; p ≤ 0.001) and PPM implantation (8% vs. 21%; p ≤ 0.001) were significantly reduced when using the cusp-overlap technique. The incidence of new LBBB (30.4% vs. 29%; p = 0.73) was similar. At 30 days, the rates of new complete heart block (11% vs. 23%; p ≤ 0.001) and PPM implantation (10% vs. 21%, p ≤ 0.001) remained significantly lower in the cusp-overlap group, while the rate of new LBBB (35% vs. 30%; p = 0.73) was similar.
Cusp-overlap approach offers several potential technical advantages compared to standard three-cusp view, and may result in lower PPM rates in TAVR with SE Evolut valve.
传导障碍和需要植入永久性起搏器(PPM)仍然是经导管主动脉瓣置换术(TAVR)的常见并发症,特别是在使用自膨式(SE)瓣膜时。
我们比较了使用传统三尖瓣共面植入技术和瓣叶交叠技术行 SE 瓣膜 TAVR 的患者住院期间和 30 天内新植入 PPM 的发生率。
我们回顾性比较了 2018 年 7 月至 2020 年 9 月在加拿大两家高容量中心使用瓣叶交叠技术行 Evolut R 或 PRO SE 瓣膜 TAVR 的无预植 PPM 患者(n=519)与 2016 年 4 月至 2017 年 3 月使用标准三尖瓣技术行 TAVR 的患者(n=128)。
两组患者的基线右束支阻滞(RBBB)无显著差异(10.4% vs. 13.2%;p=0.35)。使用瓣叶交叠技术时,住院期间新发完全性心脏阻滞(9.4% vs. 23.4%;p≤0.001)和 PPM 植入(8% vs. 21%;p≤0.001)的发生率显著降低。新发左束支阻滞(LBBB)的发生率(30.4% vs. 29%;p=0.73)相似。30 天时,瓣叶交叠组新发完全性心脏阻滞(11% vs. 23%;p≤0.001)和 PPM 植入(10% vs. 21%,p≤0.001)的发生率仍显著较低,而新发 LBBB 的发生率(35% vs. 30%;p=0.73)相似。
与标准三叶瓣视图相比,瓣叶交叠技术具有若干潜在的技术优势,可能会降低 SE Evolut 瓣膜 TAVR 后 PPM 的植入率。